Ben’s practice is focused on patent preparation, prosecution, and lifecycle management for large and small companies, as well as University clients and independent inventors. He focuses his practice in four key areas:
- Pharmaceuticals and Biotech, including pharmaceutical development, second generation filings (i.e., methods of treatment, formulations, salt and crystal forms, prodrugs, and combination therapies), and late-stage prosecution strategies to optimize patent term and protect against potential infringers/generic filers;
- Alternative Therapeutics, including nutraceuticals, food products, and Cannabis;
- Polymers and Commodity Chemicals, including plastics, natural and artificial rubbers, hydrogels, agrochemicals, and catalysts and processes for their production; and
- Fuels and Alternative Energy, including petrochemicals, natural gas, petroleum derivatives, biofuels, sustainable aviation fuel, fuel cells, batteries, and methods/processes for their production, purification, and optimization.
Ben is a member of Foley Hoag's Diversity, Equity, and Inclusion Committee.
Prior to joining the firm, Ben performed his doctoral research at the University of Virginia, where his research focused on the development of transition-metal catalysts for the conversion of natural gas and petrochemicals to higher-value commodity chemicals, such as plastics and liquid fuels. Ben’s undergraduate research at the University of Vermont focused on the synthesis and characterization of phosphorus- and silicon-containing polymers and oligomers using early-metal catalysts. He has also worked as a patent agent at another Boston law firm.
